Day: February 12, 2026

Periodic Safety Update Reports now function as inspection evidence, enabling regulators to evaluate ongoing safety surveillance, benefit–risk assessment, and pharmacovigilance system control across the product lifecycle, rather than treating PSURs as regulatory submissions.